Lineage Cell Therapeutics, Inc. Deferred Tax Liabilities, Investment in Noncontrolled Affiliates
Lineage Cell Therapeutics, Inc. (LCTX) had Deferred Tax Liabilities, Investment in Noncontrolled Affiliates of $0 as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates · last filed 2025-03-10
- 2024-12-31: Deferred Tax Liabilities, Investment in Noncontrolled Affiliates $0.00.
- 2023-12-31: Deferred Tax Liabilities, Investment in Noncontrolled Affiliates $6.00K.
- 2022-12-31: Deferred Tax Liabilities, Investment in Noncontrolled Affiliates $107.00K.
- 2021-12-31: Deferred Tax Liabilities, Investment in Noncontrolled Affiliates $789.00K.
| Period end | Deferred Tax Liabilities, Investment in Noncontrolled Affiliates | Deferred Tax Liabilities, Investment in Noncontrolled Affiliates as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-10 | |
| 2023-12-31 | $6.00K 10-K · filed 2025-03-10 | |
| 2022-12-31 | $107.00K 10-K · filed 2024-03-07 | |
| 2021-12-31 | $789.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $2.46M 10-K · filed 2022-03-10 | $15.69M 10-K · filed 2021-03-11 |
| 2019-12-31 | $19.37M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $7.85M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $23.95M 10-K · filed 2019-03-14 | -$23.95K 10-K · filed 2018-03-15 |
| 2016-12-31 | -$40.26K 10-K · filed 2018-03-15 | $40.26M 10-K · filed 2017-03-16 |
| 2015-12-31 | $1.33M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |